# Tadalafil linked to glaucoma risk

> Situation record from CLSTR: https://clstr.news/situations/tadalafil-linked-to-glaucoma-risk
> Updated: 2026-08-07T08:06:25.000Z. Sources: 23. Developments: 2.

A large observational study of 73,854 men aged 40 and older, drawn from the global TriNetX Analytics Network and conducted by researchers including those at National Taiwan University Hospital, examined eye‑health outcomes for men prescribed the erectile‑dysfunction drug tadalafil (Cialis) or other phosphodiesterase‑5 inhibitors for up to five years between 2012 and 2022. The analysis found that men on tadalafil were about 22 % more likely to develop any form of glaucoma, 33 % more likely to develop primary open‑angle glaucoma, and 32 % more likely to develop ocular hypertension, a key risk factor for the disease. They were also 33 % more likely to start glaucoma treatment during follow‑up. Researchers emphasized that the study’s observational design cannot prove causation, but they recommend regular eye‑health monitoring for long‑term tadalafil users, especially those with a family history of glaucoma or existing high eye pressure.

## Timeline

### 2026-08-07: Tadalafil use linked to 22% higher glaucoma risk in large study

A large study links daily Tadalafil use to a 22% higher risk of glaucoma and a 33% rise in primary open‑angle glaucoma, raising concerns about vision loss.

5 sources. https://clstr.news/cluster/tadalafil-use-linked-to-22-higher-glaucoma-risk-in-large-study

### 2026-08-04: Tadalafil use associated with increased glaucoma risk in men

A study of 73,854 men links long‑term tadalafil use to 22‑33% higher risks of glaucoma and ocular hypertension; experts advise eye monitoring.

18 sources. https://clstr.news/cluster/erectile-dysfunction-drugs-linked-to-glaucoma-risk-and-potential-cancerspread-inhibition

---
Cite as: Tadalafil linked to glaucoma risk. CLSTR, https://clstr.news/situations/tadalafil-linked-to-glaucoma-risk
